These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 14003842)

  • 41. Polymyositis with progressive systemic sclerosis.
    RAMOS-MORALES F; PEREYO J
    Bol Asoc Med P R; 1963 Mar; 55():140-8. PubMed ID: 13990689
    [No Abstract]   [Full Text] [Related]  

  • 42. [Scleroderma and plasma protein changes].
    LONGHI A
    Arch Ital Dermatol Sifilogr Venereol; 1952-1953; 25(6):435-52. PubMed ID: 13115085
    [No Abstract]   [Full Text] [Related]  

  • 43. Serum proteins in scleroderma.
    STAVA Z
    Dermatologica; 1958 Sep; 117(3):147-53. PubMed ID: 13585870
    [No Abstract]   [Full Text] [Related]  

  • 44. Disseminated lupus erythematosus, scleroderma, and dermatomyositis as manifestations of sensitization to DNA-protein. I. An immunohistochemical approach.
    BARDAWIL WA; TOY BL; GALINS N; BAYLES TB
    Am J Pathol; 1958; 34(4):607-29. PubMed ID: 13559396
    [No Abstract]   [Full Text] [Related]  

  • 45. [Studies on the quantity of protein metabolism in blood and on organic proteins].
    MAURER W
    Wien Z Inn Med; 1957 Oct; 38(10):393-413. PubMed ID: 13531107
    [No Abstract]   [Full Text] [Related]  

  • 46. [Collagenoses. VII. Clinical study of hydralazinic lupus erythematosus].
    SIGUIER F; BETOURNE C; BONNET DE LA TOUR J
    Bull Mem Soc Med Hop Paris; 1957 Nov 15-22; 73(29-30):992-1001. PubMed ID: 13500184
    [No Abstract]   [Full Text] [Related]  

  • 47. [Neuraminic acid and polysaccharides in serum protein fractions in the so-called collagenoses (scleroderma and lupus erythematosus)].
    DZULYNSKA J; JABLONSKA S; MAZURKIEWICZ W; PIEKARSKA Z
    Pol Tyg Lek; 1961 Jan; 16():1-10. PubMed ID: 13725466
    [No Abstract]   [Full Text] [Related]  

  • 48. THE COLLAGENOSES: TRANSITIONAL FORMS OF LUPUS ERYTHEMATOSUS, DERMATOMYOSITIS, AND SCLERODERMA.
    KIERLAND RR
    Mayo Clin Proc; 1964 Jan; 39():53-9. PubMed ID: 14105415
    [No Abstract]   [Full Text] [Related]  

  • 49. [The clinical significance of study of autoimmune processes in systemic lupus erythematosus and various other collagenoses].
    Ivanova AV; Selivanova IA
    Ter Arkh; 1968 Aug; 40(8):66-70. PubMed ID: 4393756
    [No Abstract]   [Full Text] [Related]  

  • 50. THE CUTANEOUS DIAGNOSIS OF DERMATOMYOSITIS, LUPUS ERYTHEMATOSUS, AND SCLERODERMA.
    WINKELMANN RK
    N Y State J Med; 1963 Nov; 63():3080-6. PubMed ID: 14056648
    [No Abstract]   [Full Text] [Related]  

  • 51. [Disorder of protein matabolism in several "major" collagenoses].
    ZMYZGOVA AV; KAINOVA AS; PRIVALENKO MN
    Ter Arkh; 1963 Feb; 35():99-105. PubMed ID: 14003842
    [No Abstract]   [Full Text] [Related]  

  • 52. [ASPECTS OF THE RELATIONS OF THE SKIN AND HEART IN SO-CALLED COLLAGENOSES].
    DENK R; KORTING GW
    Hautarzt; 1964 Apr; 15():147-51 CONTD. PubMed ID: 14217829
    [No Abstract]   [Full Text] [Related]  

  • 53. Life-threatening dermatoses due to connective tissue disorders.
    Katsambas A; Stefanaki C
    Clin Dermatol; 2005; 23(3):238-48. PubMed ID: 15896538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Lung and autoimmune disease--therapy].
    Hauber HP; Zabel P
    Dtsch Med Wochenschr; 2007 Aug; 132(33):1703-6. PubMed ID: 17713868
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.